SCHEMBL9822277

SCHEMBL9822277

CC(O)c1nc2nc3c(c([S])n2n1)CCC3

nearest known ligand 0.39

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.39
NPSR1 Q6W5P4 3/20 0.33
PKM P14618 1/20 0.33
KDM4E B2RXH2 2/20 0.32
ALDH1A1 P00352 2/20 0.32
CREBBP Q92793 1/20 0.32
KDM1A O60341 1/20 0.31
POLB P06746 2/20 0.31
MEN1 O00255 1/20 0.31
TSHR P16473 1/20 0.31
KMT2A Q03164 1/20 0.31
CYP1A2 P05177 1/20 0.31
GAA P10253 1/20 0.31
USP2 O75604 1/20 0.30
MAPT P10636 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9822215 0.84 LMNA (0.37) LMNANPSR1PKMKDM4EALDH1A1
SCHEMBL9822021 0.81 PKM (0.37) LMNANPSR1PKMPOLBMEN1
SCHEMBL10408137 0.75 PKM (0.45) LMNANPSR1PKMKDM4EALDH1A1
SCHEMBL9822417 0.74 LMNA (0.35) LMNANPSR1PKMKDM4EALDH1A1
SCHEMBL9822181 0.73 LMNA (0.35) LMNANPSR1PKMKDM4EALDH1A1
SCHEMBL10397427 0.71 LMNA (0.33) LMNANPSR1PKMKDM4EALDH1A1
SCHEMBL9822171 0.71 PKM (0.35) LMNANPSR1PKMKDM4EALDH1A1
SCHEMBL9822097 0.70 PKM (0.35) LMNAPKMPOLB
SCHEMBL10407380 0.70 POLB (0.39) LMNANPSR1PKMKDM4EALDH1A1
SCHEMBL10698968 0.68 KDM4E (0.36) LMNAPKMKDM4EALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4987129-A BACTERICIDES SANKEI PHARMACEUTICAL CO., LTD. (JP) 1991-01-22 US disclosed
US-4958019-A Intermediates for synthesis of cephalosporin compounds SANKEI PHARMACEUTICAL CO., LTD. (JP) 1990-09-18 US disclosed
US-4956462-A Bactericides, ANTIBIOTICS, CEPHALOSPORINS SANKEI PHARMACEUTICAL CO., LTD. (JP) 1990-09-11 US disclosed
EP-0302633-A2 Beta-lactam compound, process for preparing the same, intermediate for synthesis of the same and medicinal composition for bacterially infectious disease therapy containing the same SANKEI PHARMACEUTICAL COMPANY LIMITED (JP) 1989-02-08 EP disclosed